advanced search

Welcome: Guest

log in

The Medical Device Market: UK

Publication Date September 2009
Publisher Espicom
Product Type Report
Pages 222
ISBN Number not applicable
Product Code ESP00440
Buy this product or for assistance call +44 20 7060 7474

Summary

The UK medical device market is the third largest in Europe behind Germany and France. This report is ideal for executives wanting to understand the key drivers in the medical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Includes 3 quarterly updated outlook reports!


The UK has one of the largest medical device markets in the world, valued at US$8.4 billion in 2009. The domestic market is the third largest in Europe behind Germany and France. Per capita expenditure is not much lower in comparison to France and is equal to US$136. The UK market for medical devices is predicted to increase by 4.0% per annum at constant prices to attain a value of US$10.2 billion by 2014.

There was a period of huge growth in health spending under the Labour government, which saw the NHS budget almost triple. In 2009, the NHS budget is £98.2 billion, and will rise to £102.3 billion in 2010. However, as a result of the economic downturn, NHS funding could fall by 2.5 to 3.0 per cent per annum from 2011/12, which is equivalent to a cut of between £8 to 10 billion over three years and up to £15 billion over five years. The NHS is well equipped to deal with the financial shortage, as it has seen marked improvements in recent years.

In an effort to reduce waiting lists, the government is contracting private organisations to operate and manage independent treatment centres. In addition, as part of the Patient Choice scheme, NHS patients can now choose to have a minor operation in a private hospital and over 3,500 patients a month opt to be treated in the private sector.

The growth of the UK medical device market is predominantly import-led as many domestic manufacturers are not able to rapidly adjust to changes in demand. This led to a trade deficit for the seventh year in succession in 2008.

Payment by Results represents a dramatic change in how the NHS is financed and is key to the government’s healthcare modernisation plans. The Payment by Results scheme, combined with Patient Choice, effectively means that hospitals are competing for patients, and while this offers the opportunity to drive up standards of healthcare, it also creates an unprecedented level of financial risk for Primary Care Trusts and NHS hospitals.

MARKET OUTLOOK
Key national data projections
Current market size
Unique 5-year market projections
Market outlook
Market structure
Including statistical data on imports and exports
Market access
Including distribution and medical device regulation
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel

HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.

DISTRIBUTORS
Details of the medical equipment distributors held in Espicom’s database at the time of publication.

Content

  • 1. Executive Summary
  • 2. Introduction
  • 3. Current Market Size
  • 4. Market Projections & Outlook
  • 5. Imports
  • 6. Domestic Manufacturing
  • 7. Multinational Manufacturing
  • 8. Exports
  • 9. Distribution
  • 10. Medical Device Regulations
  • 11. Demographics
  • 12. Healthcare System
  • 13. Health Expenditure
  • 14. Healthcare Infrastructure
  • 15. Healthcare Personnel
  • 16. Directory
  • 17. Methodology & Sources
  • 97. Appendix: Healthcare Statistics
  • 98. Appendix: Distributors
Delivery Details

PDF:Delivered by email usually within 4 to 8 UK business hours.

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>